Business Is the pharma rally for real? Updated : June 22, 2018 08:05 PM IST Most pharma stocks, barring a few like Biocon, after underperforming for the past two years, have now rebounded, but investors wonder if the rally will sustain. Analysts are looking at companies that have the most scope beyond generics. There have been few compliance issues Indian companies have faced in 2018 — rather, there have been several examples of resolutions. Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.